Scroll for more

news

Apr 19, 2018 announcements

BenevolentAI raises $115 million to extend its leading global position in the field of AI enabled drug development

BenevolentAI today announced that it has raised $115 million from new and existing investors at a pre-money valuation of $2 billion in one of the largest funding rounds in the AI pharmaceutical sector.